Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Prepaid Assets came in at $3.0 million in Q4 2025, down 16.92% year-on-year from $3.6 million in Q4 2024, and down 8.75% quarter-over-quarter from $3.3 million in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Prepaid Assets history runs 13 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- On a quarterly basis, Prepaid Assets fell 16.92% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 16.92% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 16.92% from the prior year.
- Prepaid Assets declined to $3.0 million in Q4 2025 per CRBP's latest filing, from $3.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.9 million in Q2 2025 and bottomed at $791616.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $2.2 million (2022), against an average of $2.4 million.
- Across the five-year window, Prepaid Assets tumbled 66.53% in 2022 and jumped 494.21% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $2.4 million in 2021, then tumbled by 66.53% to $791616.0 in 2022, then soared by 209.24% to $2.4 million in 2023, then surged by 48.24% to $3.6 million in 2024, then fell by 16.92% to $3.0 million in 2025.
- Per Business Quant, the three latest CRBP Prepaid Assets figures stand at $3.0 million (Q4 2025), $3.3 million (Q3 2025), and $5.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 791,616.00 |
| Sep 30, 2022 | 926,161.00 |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 2.63 Mn |
| Mar 31, 2021 | 3.66 Mn |